12h
Zacks Investment Research on MSNHow to Play VKTX Stock Amid Manufacturing Deal With CordenPharmaShares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...
Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...
CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...
Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...
1d
Zacks Investment Research on MSNVKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug SupplyViking Therapeutics VKTX signed a broad multi-year manufacturing agreement with CordenPharma, a contract development and ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...
The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...
Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid ...
After Viking Therapeutics (VKTX) announced a multi-year manufacturing agreement with CordenPharma to support the commercialization of VK2735, ...
Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results